1. Home
  2. FLOC vs EOLS Comparison

FLOC vs EOLS Comparison

Compare FLOC & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLOC
  • EOLS
  • Stock Information
  • Founded
  • FLOC 1996
  • EOLS 2012
  • Country
  • FLOC United States
  • EOLS United States
  • Employees
  • FLOC N/A
  • EOLS N/A
  • Industry
  • FLOC Metal Fabrications
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLOC Industrials
  • EOLS Health Care
  • Exchange
  • FLOC Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • FLOC 417.7M
  • EOLS 493.5M
  • IPO Year
  • FLOC 2025
  • EOLS 2018
  • Fundamental
  • Price
  • FLOC $15.84
  • EOLS $7.19
  • Analyst Decision
  • FLOC Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • FLOC 6
  • EOLS 5
  • Target Price
  • FLOC $30.17
  • EOLS $21.25
  • AVG Volume (30 Days)
  • FLOC 339.9K
  • EOLS 887.7K
  • Earning Date
  • FLOC 11-06-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • FLOC 2.03%
  • EOLS N/A
  • EPS Growth
  • FLOC N/A
  • EOLS N/A
  • EPS
  • FLOC 3.01
  • EOLS N/A
  • Revenue
  • FLOC $760,923,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • FLOC $47.57
  • EOLS $14.01
  • Revenue Next Year
  • FLOC $8.14
  • EOLS $29.46
  • P/E Ratio
  • FLOC $5.24
  • EOLS N/A
  • Revenue Growth
  • FLOC 155.05
  • EOLS 17.15
  • 52 Week Low
  • FLOC $14.89
  • EOLS $5.71
  • 52 Week High
  • FLOC $30.50
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • FLOC 45.52
  • EOLS 42.33
  • Support Level
  • FLOC $15.00
  • EOLS $7.19
  • Resistance Level
  • FLOC $16.28
  • EOLS $7.75
  • Average True Range (ATR)
  • FLOC 0.53
  • EOLS 0.31
  • MACD
  • FLOC 0.08
  • EOLS 0.05
  • Stochastic Oscillator
  • FLOC 56.00
  • EOLS 0.65

About FLOC Flowco Holdings Inc. Class A Common Stock

Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: